Patent Assignment
Reel/Frame 068711/0393
Security Interest
Recorded: 2024-09-26
Pages: 6
Assignor
NAVIDEA BIOPHARMACEUTICALS, INC.
Executed: 2024-09-20
Assignee
NAVIDEA BIOPHARMACEUTICALS, INC.
4100 HORIZONS DRIVE, SUITE 205, COLUMBUS, OHIO, 43220
Covered Properties
(19)
Compositions and Methods for Assessing Macrophage Mediated Pathology
Application:
16/773,512 →
Publication:
US 2020/0237937
Compositions and Methods for Altering Macrophage Phenotype
Application:
18/174,783 →
Publication:
US 2023/0218770
Compositions and Related Methods for Blocking Off-Target Localization of Mannosylated Dextrans and Other CD206 Ligands
Application:
17/039,409 →
Publication:
US 2021/0145989
Synthesis of Uniformly Defined Molecular Weight Mannosylated Dextrans and Derivatives Thereof
Compositions and Methods for the Treatment of Rheumatoid Arthritis
Application:
17/891,450 →
Publication:
US 2023/0070258
Altering Net Charge on Mannosylated Dextrans to Maximize Target Tissue Uptake and Off Target Competitive Blocking
Competitive Self-Blocking with Unlabeled Manocept Imaging Agents
Application:
18/189,658 →
Publication:
US 2023/0302041
CD206 Targeted Drug Delivery Vehicles Carrying Novel Bisphosphonate Drug Payloads via a Degradable Linker
Mannosylated Amine Dextran Drug Delivery Vehicles with Degradable Disulfide/Carbonate Linkers Targeting Payloads to CD206 Expressing Cells
Application:
18/351,905 →
Publication:
US 2024/0024491
Amide Linkages of Sugar Moieties to Amine Terminated Leashes Attached to Carbohydrate Polymers
Bifunctional Fluorescent Molecule for Optical Imaging with Receptor Targeted Biochemical Constructs and Methods for Producing the Same
Application:
63/694,729 →
Methods for the Conjugation of Anthracyclines to Carbohydrate Polymeric Carriers
Application:
18/148,023 →
Publication:
US 2023/0210998
Compounds and Compositions for Treating Leishmaniasis and Methods of Diagnosis and Treating Using Same
Compounds and Methods for Diagnosis and Treatment of Viral Infections
Patent:
11,007,272 →
Application:
15/729,635 →
Compounds and Methods for Diagnosis and Treatment of Viral Infections
Compositions and Methods for Altering Macrophage Phenotype
Synthesis of Uniformly Defined Molecular Weight Mannosylated Dextrans and Derivatives Thereof
Altering Net Charge on Mannosylated Dextrans to Maximize Target Tissue Uptake and Off Target Competitive Blocking
CD206 Targeted Drug Delivery Vehicles Carrying Novel Bisphosphonate Drug Payloads via a Degradable Linker
Related Assignments
(24)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Jul 11, 2019
From: COPE, FREDERICK O.
To: NAVIDEA BIOPHARMACEUTICALS, INC.
Reel/Frame 049727/0618 →
Assignment of Assignor's Interest
Jul 11, 2019
From: COPE, FREDERICK O.
To: NAVIDEA BIOPHARMACEUTICALS, INC.
Reel/Frame 049728/0616 →
Assignment of Assignor's Interest
Aug 13, 2019
From: COPE, FREDERICK O.
To: NAVIDEA BIOPHARMACEUTICALS, INC.
Reel/Frame 050040/0350 →
Assignment of Assignor's Interest
Oct 2, 2020
From: RALPH, DAVID A.
To: NAVIDEA BIOPHARMACEUTICALS, INC.
Reel/Frame 053961/0768 →
Assignment of Assignor's Interest
Apr 14, 2021
From: RALPH, DAVID A.
To: NAVIDEA BIOPHARMACEUTICALS, INC.
Reel/Frame 055925/0960 →
Assignment of Assignor's Interest
Apr 14, 2022
From: RALPH, DAVID A.
To: NAVIDEA BIOPHARMACEUTICALS, INC.
Reel/Frame 059717/0340 →
Assignment of Assignor's Interest
Apr 14, 2022
From: RALPH, DAVID A.
To: NAVIDEA BIOPHARMACEUTICALS, INC.
Reel/Frame 059716/0035 →
Assignment of Assignor's Interest
Apr 14, 2022
From: COPE, FREDERICK O.
To: NAVIDEA BIOPHARMACEUTICALS, INC.
Reel/Frame 059596/0017 →
Assignment of Assignor's Interest
Oct 5, 2022
From: RALPH, DAVID A.; ROSOL, MICHAEL
To: NAVIDEA BIOPHARMACEUTICALS, INC.
Reel/Frame 061316/0209 →
Assignment of Assignor's Interest
Jan 6, 2023
From: ARNOLD, JEFFREY; RALPH, DAVID A.
To: NAVIDEA BIOPHARMACEUTICALS, INC.
Reel/Frame 062291/0257 →
Assignment of Assignor's Interest
Feb 15, 2023
From: RALPH, DAVID A.; ROSOL, MICHAEL; ISMAIL, AHMAD; KISSLING, ALLISON
To: NAVIDEA BIOPHARMACEUTICALS, INC.
Reel/Frame 062705/0278 →
Assignment of Assignor's Interest
Feb 27, 2023
From: RALPH, DAVID A.
To: NAVIDEA BIOPHARMACEUTICALS, INC.
Reel/Frame 062875/0041 →
Assignment of Assignor's Interest
Mar 6, 2023
From: RALPH, DAVID A.; ARNOLD, JEFFREY
To: NAVIDEA BIOPHARMACEUTICALS, INC.
Reel/Frame 062892/0840 →
Assignment of Assignor's Interest
Apr 17, 2023
From: RALPH, DAVID A.; ARNOLD, JEFFREY
To: NAVIDEA BIOPHARMACEUTICALS, INC.
Reel/Frame 063344/0799 →
Assignment of Assignor's Interest
Apr 25, 2023
From: RALPH, DAVID A.
To: NAVIDEA BIOPHARMACEUTICALS, INC.
Reel/Frame 063427/0666 →
Assignment of Assignor's Interest
Jul 25, 2023
From: RALPH, DAVID A.; ARNOLD, JEFFREY SCOTT
To: NAVIDEA BIOPHARMACEUTICALS, INC.
Reel/Frame 064373/0660 →
Assignment of Assignor's Interest
Aug 9, 2023
From: RALPH, DAVID A.; ARNOLD, JEFFREY SCOTT
To: NAVIDEA BIOPHARMACEUTICALS, INC.
Reel/Frame 064533/0659 →
Assignment of Assignor's Interest
Aug 23, 2023
From: ARNOLD, JEFFREY SCOTT; RALPH, DAVID A.
To: NAVIDEA BIOPHARMACEUTICALS, INC.
Reel/Frame 064679/0315 →
Assignment of Assignor's Interest
Nov 17, 2023
From: ARNOLD, JEFFREY; RALPH, DAVID A.
To: NAVIDEA BIOPHARMACEUTICALS, INC.
Reel/Frame 065603/0628 →
Assignment of Assignor's Interest
Feb 20, 2024
From: RALPH, DAVID A.; ARNOLD, JEFFREY SCOTT
To: NAVIDEA BIOPHARMACEUTICALS, INC.
Reel/Frame 066501/0163 →
Assignment of Assignor's Interest
May 15, 2024
From: RALPH, DAVID A.; ARNOLD, JEFFREY SCOTT
To: NAVIDEA BIOPHARMACEUTICALS, INC.
Reel/Frame 067423/0223 →
Corrective Assignment to Correct the Receiving Party Information Previously Recorded on Reel 68711 Frame 393. Assignor(S) Hereby Confirms the Security Agreement.
Sep 27, 2024
From: NAVIDEA BIOPHARMACEUTICALS, INC.
To: SCOTT, JOHN KIM, JR.
Reel/Frame 069165/0332 →
Assignment of Assignor's Interest
Jul 2, 2025
From: ARNOLD, JEFFREY SCOTT; RALPH, DAVID A.
To: NAVIDEA BIOPHARMACEUTICALS, INC.
Reel/Frame 071788/0318 →
Us Bankruptcy Court Sale Order Dated Jan. 30, 2026 to Release Security Interest Recorded at 069165 / 0332
Feb 12, 2026
From: SCOTT, JOHN KIM, JR.
To: NAVIDEA BIOPHARMACEUTICALS, INC.
Reel/Frame 074831/0644 →